Skip to content

Addiction: all studies

Page 101 of 855: studies 1,001 to 1,010 of 8,547, newest first. Back to the addiction overview

Research

Psychiatric comorbidities in a young man with subacute myelopathy induced by abusive nitrous oxide consumption: a case report.

Substance Abuse and Rehabilitation 2016 Falk Mancke, Gintarė Kaklauskaitė, Jennifer Kollmer et al.

Nitrous oxide (N2O), a long-standing anesthetic, is known for its recreational use, and its consumption is on the rise. Several case studies have reported neurological and psychiatric complications of N2O use. To date, however, there has not been a study using standardized diagnostic procedures to assess psychiatric comorbidities in a patient consuming N2O. Here, we report about a 35-year-old...

DOI: 10.2147/sar.s114404 (opens in new tab) Full text (opens in new tab) Substance use disorder Addictive disorders Laughing gas Subacute combined degeneration +1

The Legal Highs of Novel Drugs of Abuse

Journal of Drug Abuse 2016 Pierluigi Pompei 4 citations

Abstract The abuse of drugs is a widespread and growing issue, both in United States and Europe, as a number of synthetic drugs have raised popularity over the past years for recreational use. Moreover, the nature of addiction is often debated as either a lifestyle choice that may underline a physiological vulnerability, or a chronic brain disease with remarkable epigenetic, neurodevelopmental...

DOI: 10.21767/2471-853x.100025 (opens in new tab) Full text (opens in new tab) Addiction Synthetic cannabinoids Recreational drug Drugs of abuse +1

Acute oral 18-methoxycoronaridine (18-MC) decreases both alcohol intake and IV nicotine self-administration in rats.

Pharmacology, Biochemistry, and Behavior 2016 Amir H Rezvani, Marty C Cauley, Susan Slade et al. 22 citations

The ibogaine derivative 18-methoxycoronaridine (18-MC) has been found to decrease self-administration of morphine, nicotine and alcohol in rats after systemic injection. However oral dosing is the preferred route clinically. The current study evaluated the effect of oral 18-MC dosing in rats on alcohol and nicotine self-administration. For the nicotine study, young adult female Sprague-Dawley...

DOI: 10.1016/j.pbb.2016.10.010 (opens in new tab) Full text (opens in new tab) Alcohol preferring rat Drinking Addiction treatment Alcoholism research +2

Noribogaine is a G-protein biased κ-opioid receptor agonist.

Neuropharmacology December 1, 2015 Émeline L. Maillet, Nicolas Milon, Mari D. Heghinian et al. 59 citations

Noribogaine is the long-lived human metabolite of the anti-addictive substance ibogaine. Noribogaine efficaciously reaches the brain with concentrations up to 20 μM after acute therapeutic dose of 40 mg/kg ibogaine in animals. Noribogaine displays atypical opioid-like components in vivo, anti-addictive effects and potent modulatory properties of the tolerance to opiates for which the mode of...

DOI: 10.1016/j.neuropharm.2015.08.032 (opens in new tab) Full text (opens in new tab) 18-mc Analgesia Beta-arrestin pathway Biased agonist +19

Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities

Psychopharmacology November 27, 2015 Joaquim Soler, Matilde Elices, Alba Franquesa et al. 212 citations

BackgroundAyahuasca is a psychotropic plant tea used for ritual purposes by the indigenous populations of the Amazon. In the last two decades, its use has expanded worldwide. The tea contains the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT), plus β-carboline alkaloids with monoamine-oxidase-inhibiting properties. Acute administration induces an introspective dream-like...

Psychedelic medicine: a re-emerging therapeutic paradigm

Canadian Medical Association Journal September 8, 2015 Kenneth W. Tupper, Evan Wood, Richard Yensen et al. 189 citations

In clinical research settings around the world, renewed investigations are taking place on the use of psychedelic substances for treating illnesses such as addiction, depression, anxiety and posttraumatic stress disorder (PTSD). Since the termination of a period of research from the 1950s to the

Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume.

The International Journal of Neuropsychopharmacology June 4, 2015 Reagan R Wetherill, Kanchana Jagannathan, Nathan M. Hager et al.

Structural magnetic resonance imaging techniques are powerful tools for examining the effects of drug use on the brain. The nicotine and cannabis literature has demonstrated differences between nicotine cigarette smokers and cannabis users compared to controls in brain structure; however, less is known about the effects of co-occurring cannabis and tobacco use. We used voxel-based morphometry...

Noribogaine reduces nicotine self-administration in rats.

Journal of Psychopharmacology June 1, 2015 Qing Chang, Taleen Hanania, Deborah C. Mash et al. 26 citations

Noribogaine, a polypharmacological drug with activities at opioid receptors, ionotropic nicotinic receptors, and serotonin reuptake transporters, has been investigated for treatment of substance abuse-related disorders. Smoking cessation has major benefits for both individuals and society, therefore the aim of this study was to evaluate the potential of noribogaine for use as a treatment for...

DOI: 10.1177/0269881115584461 (opens in new tab) Full text (opens in new tab) Food self-administration Nicotine addiction treatment Noribogaine pharmacology Behavioral specificity

Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA

Behavioural Pharmacology May 14, 2015 María Pilar García-pardo, Carla Escobar-Valero, Marta Rodrı́guez-arias et al. 29 citations

Some 3,4-methylenedioxymethamphetamine (MDMA) users become dependent as a result of chronic consumption. A greater understanding of the neurobiological basis of the rewarding effects of MDMA could contribute to developing effective pharmacotherapies for MDMA-related problems. The present study evaluated the role of N-methyl-D-aspartate (NMDA) glutamate receptors (NMDARs) in the acquisition and...

DOI: 10.1097/fbp.0000000000000138 (opens in new tab) MDMA Addiction Conditioned place preference Memantine +5